欧洲临床研究杂志 SCIE

期刊简介预计审稿时间： 约1月

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考虑从最复杂的基础分子科学到广泛分支学科的应用临床和转化研究以及循证医学的任何原创贡献。EJCI 发表与人类生物学和疾病的遗传、分子、细胞或生理基础有关的高质量研究报告，以及涉及疾病的流行、诊断、过程、治疗和预防的研究。我们主要对与人类直接相关的研究感兴趣，但也鼓励提交可靠的体外和动物研究。该期刊非常重视使用创新方法以及实验室、临床和流行病学方法和技术组合的跨学科工作和研究。几类稿件（详细描述见下文）将被考虑：社论、原创文章（还包括随机临床试验、系统评价和荟萃分析）、评论（叙述性评论）、意见文章（包括辩论、观点和评论）；以及致编辑的信。

《European Journal Of Clinical Investigation》(欧洲临床研究杂志)编辑部通讯方式为WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。